The pet test can be used to help determine Parkinson’s disease.
Parkinson’s disease is usually diagnosed clinically based on symptoms, but if levodopa treatment is not effective and there is doubt about the condition, it is recommended that a brain PET test be performed.
The principle of PET-CT is to apply radionuclides to label physiological substances involved in normal metabolism, such as amino acids and glucose. They are formed at various stages of the disease. After being introduced into the body, the highly relevant and characteristic tracers are involved in cellular metabolism, which facilitates the tracking of metabolic differences between normal and diseased tissues and helps to diagnose Parkinson’s disease.
Parkinson’s disease is a common neurodegenerative disease in the elderly, and its main symptoms include hand tremor at rest, bradykinesia and myotonia, and postural balance disorders, which may also be accompanied by constipation, smell disorders, sleep disorders, mood abnormalities, and cognitive disorders.
It is recommended that people with related symptoms consult a doctor in time, and once the diagnosis is confirmed, active treatment is needed.